Penserra Capital Management LLC Pliant Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$12.27 - $18.26 $10,061 - $14,973	-820 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$16.48 - $28.98 $82 - $144	5 Added 0.61%	820 $13,000
Q2 2021 Aug 12, 2021	BUY	$28.05 - $37.69 $420 - $565	15 Added 1.88%	815 $23,000
Q1 2021 May 13, 2021	SELL	$24.52 - $40.23 $613 - $1,005	-25 Reduced 3.03%	800 $31,000
Q4 2020 Feb 12, 2021	BUY	$19.89 - $32.99 $16,409 - $27,216	825 New	825 $18,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.